Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ekström M[au]:

Oxygen Therapy in Suspected Acute Myocardial Infarction. Hofmann R et al. N Engl J Med. (2017)

Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward. Ekström M et al. Int J Chron Obstruct Pulmon Dis. (2018)

Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden. Ekström M et al. Allergy. (2019)

Search results

Items: 1 to 50 of 173

1.

Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.

Currow D, Louw S, McCloud P, Fazekas B, Plummer J, McDonald CF, Agar M, Clark K, McCaffery N, Ekström MP; Australian National Palliative Care Clinical Studies Collaborative (PaCCSC).

Thorax. 2019 Sep 26. pii: thoraxjnl-2019-213681. doi: 10.1136/thoraxjnl-2019-213681. [Epub ahead of print]

PMID:
31558624
2.

Fan therapy is a treatment option for relieving of chronic breathlessness.

Ekström M.

Evid Based Nurs. 2019 Sep 11. pii: ebnurs-2019-103118. doi: 10.1136/ebnurs-2019-103118. [Epub ahead of print] No abstract available.

PMID:
31511243
3.

The association of body mass index, weight gain and central obesity with activity-related breathlessness: the Swedish Cardiopulmonary Bioimage Study.

Ekström MP, Blomberg A, Bergström G, Brandberg J, Caidahl K, Engström G, Engvall J, Eriksson M, Gränsbo K, Hansen T, Jernberg T, Nilsson L, Nilsson U, Olin AC, Persson L, Rosengren A, Sandelin M, Sköld M, Sundström J, Swahn E, Söderberg S, Tanash HA, Torén K, Östgren CJ, Lindberg E.

Thorax. 2019 Oct;74(10):958-964. doi: 10.1136/thoraxjnl-2019-213349. Epub 2019 Aug 21.

PMID:
31434752
4.

Patient registries for home oxygen research and evaluation.

Lacasse Y, Krishnan JA, Maltais F, Ekström M.

Int J Chron Obstruct Pulmon Dis. 2019 Jun 18;14:1299-1304. doi: 10.2147/COPD.S204391. eCollection 2019.

5.

Differences between experienced and recalled breathlessness: a review.

Sandberg J, Ekström M.

Curr Opin Support Palliat Care. 2019 Jul 11. doi: 10.1097/SPC.0000000000000448. [Epub ahead of print]

PMID:
31389844
6.

Differences between experienced and recalled breathlessness: a review.

Sandberg J, Ekström M.

Curr Opin Support Palliat Care. 2019 Sep;13(3):161-166. doi: 10.1097/SPC.0000000000000448.

PMID:
31365460
7.

Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion.

Ekström M.

Curr Opin Support Palliat Care. 2019 Sep;13(3):179-183. doi: 10.1097/SPC.0000000000000444.

PMID:
31246594
8.

Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden.

Ekström M, Nwaru BI, Hasvold P, Wiklund F, Telg G, Janson C.

Allergy. 2019 May 16. doi: 10.1111/all.13874. [Epub ahead of print]

PMID:
31095758
9.

Calculated arterial blood gas values from a venous sample and pulse oximetry: Clinical validation.

Ekström M, Engblom A, Ilic A, Holthius N, Nordström P, Vaara I.

PLoS One. 2019 Apr 12;14(4):e0215413. doi: 10.1371/journal.pone.0215413. eCollection 2019.

10.

Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application.

Sandberg J, Lansing R, Anderberg P, Currow D, Sundh J, Ahmadi Z, Palmqvist S, Ekström M.

BMJ Open Respir Res. 2019 Feb 12;6(1):e000370. doi: 10.1136/bmjresp-2018-000370. eCollection 2019.

11.

The trajectory of functional decline over the last 4 months of life in a palliative care population: A prospective, consecutive cohort study.

Morgan DD, Tieman JJ, Allingham SF, Ekström MP, Connolly A, Currow DC.

Palliat Med. 2019 Jun;33(6):693-703. doi: 10.1177/0269216319839024. Epub 2019 Mar 27.

PMID:
30916620
12.

Breathlessness and incidence of COPD, cardiac events and all-cause mortality: A 44-year follow-up from middle age throughout life.

Sandberg J, Engström G, Ekström M.

PLoS One. 2019 Mar 18;14(3):e0214083. doi: 10.1371/journal.pone.0214083. eCollection 2019.

13.

REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol.

Sundh J, Bornefalk-Hermansson A, Ahmadi Z, Blomberg A, Janson C, Currow DC, McDonald CF, McCaffrey N, Ekström M.

BMC Pulm Med. 2019 Feb 26;19(1):50. doi: 10.1186/s12890-019-0809-7.

14.

Effectiveness trials: critical data to help understand how respiratory medicines really work?

Heddini A, Sundh J, Ekström M, Janson C.

Eur Clin Respir J. 2019 Jan 29;6(1):1565804. doi: 10.1080/20018525.2019.1565804. eCollection 2019. Review.

15.

Sertraline or placebo in chronic breathlessness? Lessons from placebo research.

Currow DC, Agar M, Ekström M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802316. doi: 10.1183/13993003.02316-2018. Print 2019 Jan. No abstract available.

PMID:
30655452
16.

Agreement Between Breathlessness Severity and Unpleasantness in People With Chronic Breathlessness: A Longitudinal Clinical Study.

Ekström M, Williams M, Johnson MJ, Huang C, Currow DC.

J Pain Symptom Manage. 2019 Apr;57(4):715-723.e5. doi: 10.1016/j.jpainsymman.2019.01.001. Epub 2019 Jan 10.

PMID:
30639756
17.

Statistical compared to clinical significance and the risk of misattribution.

Ekström M, Johnson MJ, Currow DC.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801723. doi: 10.1183/13993003.01723-2018. Print 2018 Nov. No abstract available.

PMID:
30498053
18.

Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.

Currow DC, Ekström M, Louw S, Hill J, Fazekas B, Clark K, Davidson PM, McDonald C, Sajkov D, McCaffrey N, Doogue M, Abernethy AP, Agar M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1801270. doi: 10.1183/13993003.01270-2018. Print 2019 Jan.

PMID:
30361250
19.

Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study.

Bajwah S, Davies JM, Tanash H, Currow DC, Oluyase AO, Ekström M.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801278. doi: 10.1183/13993003.01278-2018. Print 2018 Dec.

PMID:
30309973
20.

Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients.

Sundh J, Ahmadi Z, Ekström M.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2623-2628. doi: 10.2147/COPD.S167523. eCollection 2018.

21.

Antithrombotic treatment and risk of complications after head and neck full thickness skin graft surgery.

Hasselgren M, Runer T, Janson P, Ekström M.

J Plast Surg Hand Surg. 2018 Dec;52(6):333-337. doi: 10.1080/2000656X.2018.1498789. Epub 2018 Sep 4.

PMID:
30178690
22.

Factors influencing adherence to continuous positive airway pressure treatment in obstructive sleep apnea and mortality associated with treatment failure - a national registry-based cohort study.

Palm A, Midgren B, Theorell-Haglöw J, Ekström M, Ljunggren M, Janson C, Lindberg E.

Sleep Med. 2018 Nov;51:85-91. doi: 10.1016/j.sleep.2018.07.007. Epub 2018 Jul 17.

PMID:
30103074
23.

Missed opportunity? Worsening breathlessness as a harbinger of death: a cohort study.

Currow DC, Smith JM, Chansriwong P, Noble SIR, Nikolaidou T, Ferreira D, Johnson MJ, Ekström M.

Eur Respir J. 2018 Sep 6;52(3). pii: 1800684. doi: 10.1183/13993003.00684-2018. Print 2018 Sep.

PMID:
30049740
24.

Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Ferreira DH, Ekström M, Sajkov D, Vandersman Z, Eckert DJ, Currow DC.

J Pain Symptom Manage. 2018 Oct;56(4):483-492. doi: 10.1016/j.jpainsymman.2018.07.010. Epub 2018 Jul 19.

PMID:
30031217
25.

Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial.

Ahmadi Z, Sandberg J, Shannon-Honson A, Vandersman Z, Currow DC, Ekström M.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800887. doi: 10.1183/13993003.00887-2018. Print 2018 Sep. No abstract available.

26.

Analysing data in palliative care trials.

Hussain JA, White IR, Johnson MJ, Ekstrom M, Currow DC.

BMJ. 2018 Jul 10;362:k2943. doi: 10.1136/bmj.k2943. No abstract available.

PMID:
29991516
27.

Breathlessness and sexual activity in older adults: the Australian Longitudinal Study of Ageing.

Ekström M, Johnson MJ, Taylor B, Luszcz M, Wohland P, Ferreira DH, Currow DC.

NPJ Prim Care Respir Med. 2018 Jun 22;28(1):20. doi: 10.1038/s41533-018-0090-x.

28.

Toward Shared Working Space of Human and Robotic Agents Through Dipole Flow Field for Dependable Path Planning.

Trinh LA, Ekström M, Cürüklü B.

Front Neurorobot. 2018 Jun 6;12:28. doi: 10.3389/fnbot.2018.00028. eCollection 2018.

29.

Breathlessness measurement should be standardised for the level of exertion.

Ekström M, Elmberg V, Lindow T, Wollmer P.

Eur Respir J. 2018 May 30;51(5). pii: 1800486. doi: 10.1183/13993003.00486-2018. Print 2018 May. No abstract available.

PMID:
29848576
30.

Job titles classified into socioeconomic and occupational groups identify subjects with increased risk for respiratory symptoms independent of occupational exposure to vapour, gas, dust, or fumes.

Schyllert C, Andersson M, Hedman L, Ekström M, Backman H, Lindberg A, Rönmark E.

Eur Clin Respir J. 2018 May 15;5(1):1468715. doi: 10.1080/20018525.2018.1468715. eCollection 2018.

31.

Occupational risk factors for idiopathic pulmonary fibrosis in Southern Europe: a case-control study.

Paolocci G, Folletti I, Torén K, Ekström M, Dell'Omo M, Muzi G, Murgia N.

BMC Pulm Med. 2018 May 21;18(1):75. doi: 10.1186/s12890-018-0644-2.

32.

Evaluation of the IngVaL Pedobarography System for Monitoring of Walking Speed.

Hellstrom PAR, Åkerberg A, Ekström M, Folke M.

Healthc Inform Res. 2018 Apr;24(2):118-124. doi: 10.4258/hir.2018.24.2.118. Epub 2018 Apr 30.

33.

Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.

Sandberg J, Johnson MJ, Currow DC, Ekström M.

J Pain Symptom Manage. 2018 Sep;56(3):430-435.e2. doi: 10.1016/j.jpainsymman.2018.05.002. Epub 2018 May 10.

PMID:
29753099
34.

Spirometric Volumes and Breathlessness Across Levels of Airflow Limitation: The COPDGene Study.

Ekström M, Bornefalk-Hermansson A, Wysham N, Currow DC, MacIntyre N.

Am J Respir Crit Care Med. 2018 Apr 27. doi: 10.1164/rccm.201803-0594LE. [Epub ahead of print] No abstract available.

35.

Chronic breathlessness: re-thinking the symptom.

Johnson MJ, Yorke J, Hansen-Flaschen J, Ekström M, Currow DC.

Eur Respir J. 2018 Apr 12;51(4). pii: 1800340. doi: 10.1183/13993003.00340-2018. Print 2018 Apr. No abstract available.

36.

Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward.

Ekström M, Ringbaek T.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 9;13:231-235. doi: 10.2147/COPD.S148673. eCollection 2018. Review.

37.

Further Need for Evidence in Long-Term Oxygen Therapy.

Ekström M, Ahmadi Z, Sundh J.

Ann Am Thorac Soc. 2018 Apr;15(4):511-512. doi: 10.1513/AnnalsATS.201801-023LE. No abstract available.

PMID:
29384689
38.

Chronic breathlessness: re-thinking the symptom.

Johnson MJ, Yorke J, Hansen-Flaschen J, Lansing R, Ekström M, Currow DC.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702326. doi: 10.1183/13993003.02326-2017. Print 2018 Jan. No abstract available.

39.

Ensuring caregivers are part of palliative care service delivery.

Currow DC, Johnson MJ, Ekström M.

Palliat Support Care. 2018 Oct;16(5):639-640. doi: 10.1017/S1478951517001262. Epub 2018 Jan 24. No abstract available.

PMID:
29361996
40.

The strength of evidence: low dose morphine for chronic breathlessness.

Currow DC, Ekström M, Johnson MJ.

Intern Med J. 2018 Jan;48(1):102-103. doi: 10.1111/imj.13660. No abstract available.

PMID:
29314519
41.

Absolute lung size and the sex difference in breathlessness in the general population.

Ekström M, Sundh J, Schiöler L, Lindberg E, Rosengren A, Bergström G, Angerås O, Hedner J, Brandberg J, Bake B, Torén K.

PLoS One. 2018 Jan 5;13(1):e0190876. doi: 10.1371/journal.pone.0190876. eCollection 2018.

42.

Non-invasive positive pressure ventilation should be considered in patients with COPD and persistent hypercapnia at least 2 weeks after resolution of acute respiratory failure.

Ekström M.

Evid Based Nurs. 2018 Jan;21(1):12. doi: 10.1136/eb-2017-102789. Epub 2017 Nov 25. No abstract available.

PMID:
29175966
43.

Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status.

Ekström M, Tanash H.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 7;12:3281-3287. doi: 10.2147/COPD.S148509. eCollection 2017.

44.

A nationwide structure for valid long-term oxygen therapy: 29-year prospective data in Sweden.

Ekström M, Ahmadi Z, Larsson H, Nilsson T, Wahlberg J, Ström KE, Midgren B.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 30;12:3159-3169. doi: 10.2147/COPD.S140264. eCollection 2017.

45.

Conference presentation in palliative medicine: predictors of subsequent publication.

Hanchanale S, Kerr M, Ashwood P, Curran E, Ekstrom M, Allen S, Currow D, Johnson MJ.

BMJ Support Palliat Care. 2018 Mar;8(1):73-77. doi: 10.1136/bmjspcare-2017-001425. Epub 2017 Nov 10.

PMID:
29127139
46.

Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

Hagbom M, Novak D, Ekström M, Khalid Y, Andersson M, Lindh M, Nordgren J, Svensson L.

PLoS One. 2017 Oct 27;12(10):e0186824. doi: 10.1371/journal.pone.0186824. eCollection 2017.

47.

Risk of cancer after lung transplantation for COPD.

Ekström M, Riise GC, Tanash HA.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 3;12:2841-2847. doi: 10.2147/COPD.S147065. eCollection 2017.

48.

Breathlessness despite optimal pathophysiological treatment: on the relevance of being chronic.

Johnson MJ, Yorke J, Hansen-Flaschen J, Lansing R, Ekström M, Currow DC.

Eur Respir J. 2017 Sep 27;50(3). pii: 1701297. doi: 10.1183/13993003.01297-2017. Print 2017 Sep. No abstract available.

49.

The independent association of overweight and obesity with breathlessness in adults: a cross-sectional, population-based study.

Currow DC, Dal Grande E, Sidhu C, Ekström M, Johnson MJ.

Eur Respir J. 2017 Sep 27;50(3). pii: 1700558. doi: 10.1183/13993003.00558-2017. Print 2017 Sep. No abstract available.

50.

Overdosing on immediate-release morphine solution has predictable adverse effects.

Currow DC, Ekström M, Johnson MJ.

Eur Respir J. 2017 Sep 9;50(3). pii: 1701091. doi: 10.1183/13993003.01091-2017. Print 2017 Sep. No abstract available.

Supplemental Content

Loading ...
Support Center